Tetraphase Pharmaceuticals, Inc.
TTPH
TTPH was delisted on the 28th of July, 2020.
94 hedge funds and large institutions have $70.7M invested in Tetraphase Pharmaceuticals, Inc. in 2018 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 30 increasing their positions, 26 reducing their positions, and 23 closing their positions.
88% more call options, than puts
Call options by funds: $815K | Put options by funds: $434K
15% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 26
9% less funds holding
Funds holding: 103 → 94 (-9)
30% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 23
63% less capital invested
Capital invested by funds: $191M → $70.7M (-$120M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
6CM
683 Capital Management
New York
|
+$2.63M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.8M |
| 3 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$1.62M |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.61M |
| 5 |
Renaissance Technologies
New York
|
+$1.58M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$16.1M |
| 2 |
Millennium Management
New York
|
-$11.3M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.23M |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$5.99M |
| 5 |
JP Morgan Chase
New York
|
-$4.53M |
TTPH Hedge Fund Activity: Q1 2018 in Review
94 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Tetraphase Pharmaceuticals, Inc. (TTPH) for Q1 2018, worth a combined $70.7M — down 63% from $191M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of TTPH and 16 opened new positions — a net loss of 7 holders — while 26 trimmed existing stakes and 30 added.
The largest buyer was 683 Capital Management, opening a new position worth an estimated $2.63M. The largest seller was Canada Pension Plan Investment Board, exiting entirely with an estimated $16.1M sold.
- 94 institutional investors held Tetraphase Pharmaceuticals, Inc. (TTPH) as of Q1 2018, down from 103 in Q4 2017.
- Funds reported $70.7M of Tetraphase Pharmaceuticals, Inc. stock for Q1 2018, down 63% quarter-over-quarter.
- 16 funds opened new Tetraphase Pharmaceuticals, Inc. positions in Q1 2018 and 23 closed out, a net change of -7 holders.
- The largest Tetraphase Pharmaceuticals, Inc. buyer in Q1 2018 was 683 Capital Management, an estimated $2.63M added.
- The largest Tetraphase Pharmaceuticals, Inc. seller in Q1 2018 was Canada Pension Plan Investment Board, an estimated $16.1M sold.
Based on aggregated 13F filings for Q1 2018.